CervoMed Inc. Derivative Liability, Current
CervoMed Inc. (CRVO) had Derivative Liability, Current of $16.32 million as of 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2017-11-13
- 2017-09-30: Derivative Liability, Current $16.32M.
- 2017-06-30: Derivative Liability, Current $24.76M.
- 2017-03-31: Derivative Liability, Current $48.15M.
- 2016-12-31: Derivative Liability, Current $0.00.
| Period end | Derivative Liability, Current |
|---|---|
| 2017-09-30 | $16.32M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $24.76M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $48.15M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $0.00 10-Q · filed 2017-05-15 |
| 2013-12-31 | $0.00 10-K/A · filed 2014-04-23 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-19 |
| 2013-03-31 | $10.63M 10-Q/A · filed 2013-05-20 |
| 2012-12-31 | $10.39M 10-K/A · filed 2014-04-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |